Under construction – not a live service
Sign in

NCT05427578Completed

Brain Markers of Depression Vulnerability: the Case of Prefrontal Haemodynamic Response

Source: ClinicalTrials.gov · Last updated 11 Dec 2025

Brief summary (registry, in English)

Functional near infrared spectroscopy (fNIRS) offers a cheap and reliable tool to investigate prefrontal brain activation in the healthy and diseased human brain. As such, fNIRS bears great potential as a diagnostic tool for clinical practice. Research indicates that fNIRS, together with a relatively simple task to activate the prefrontal cortex, the so-called verbal fluency task (VFT), elucidates prefrontal dysfunction in major depressive disorder (MDD). This finding can potentially serve as an imaging marker for disease pathology, even when depressive symptoms are absent. Indeed, recent research also suggests prefrontal dysfunction in fully remitted MDD (rMDD). Prefrontal haemodynamic responses may therefore serve as a trait marker for MDD vulnerability. This study aims to investigate the haemodynamic response in rMDD, healthy participants with increased MDD risk (HCr; having a 1st-degree relative with MDD), and low-risk healthy participants (HCnr; having no 1st-degree relatives with MDD) using fNIRS. The investigators hypothesize lower prefrontal reactivity in HCr compared to HCnr, and lowest prefrontal reactivity in rMDD compared to HCnr. This study has the potential to elucidate the neuronal underpinnings of depression vulnerability in the absence of symptoms that are sometimes considered a confounding factor when it comes to studying the biological encoding of depression.

Status (registry)
Completed
Study type
Observational
Enrollment
90 (actual)
First submitted
16 Jun 2022
Start date
1 Aug 2021
Primary completion date
29 Nov 2024
Lead sponsor
Dr Georg Kranz
Diseases
Depression
NCT number
NCT05427578

What you commit to

  • Study type: Observational
  • Participants enrolled: 90
  • From 1 Aug 2021 to the primary completion date, 29 Nov 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Current diagnosis of psychiatric disorders, such as depression, anxiety, schizophrenia, or autism
  • current or past diagnosis of neurological disorders, such as head injuries, strokes, encephalitis, epilepsy, Parkinson's, or Alzheimer's

Who the study is looking for

  • Mini-mental state examination (MMSE) > 24

Age in the registry: 18 years to 35 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
The Hong Kong Polytechnic University
Coordinator of this site? Confirm its status
Hong KongHong KongUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.